Nisha S Joseph

8PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - inorganic elements and compoundsMedical virologyInnate immunityChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 13, 2024
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.

Nisha S Joseph, Jonathan L Kaufman, Vilas A Gupta

|Jul 07, 2023
Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction.

Laura F Sun, Kathryn T Maples, Kevin H Hall

|Dec 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.

Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram

|Mar 08, 2022
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.

Ajay K Nooka, Uma Shanmugasundaram, Narayana Cheedarla

|Aug 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myeloma.

Ajay K Nooka, Nisha S Joseph, Sagar Lonial

|May 16, 2019
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.

Ajay K Nooka, Nisha S Joseph, Jonathan L Kaufman

Pageof 2

Frequent Collaborators

8 joint publications

Ajay K Nooka

5 joint publications

Madhav V Dhodapkar

5 joint publications

Jonathan L Kaufman

5 joint publications

Craig C Hofmeister